Discussion in 'Community' started by VadersLaMent, Oct 12, 2015.
On the previous page we have Church in possible human trials in a couple of years. We have Bill Andrews doing human trials this year.
And here is Aubrey de Grey with potential human trials by 2021
More with Liz and others.
Indefinitely. I certainly don’t want to die of a disease like old age, even if it’s a disease society largely accepts because they’ve previously had no choice
I made a short film on this subject, it has always interested me. Shot in 4K with a private jet, yacht, crane and Ferrari shots, we had it all. Lots of fun. Didn’t go as far as I wanted, usual criticism was it looks beautiful and well made but no true ending, they didn’t like the cliffhanger for a short, Blah blah whatever don’t agree with any of it but not offended either as it was years ago and well past. I made it as a jumping off point to a feature so I didn’t really care if some festivals didn’t think it had closure as for me that was the point - it was a start not an end. Started with a quote from Aubrey
Why is everyone just on their phones in the opening? What’s the point of that?
Eugene isn’t a great actor, but the main guy is decent
Too much dialogue, jeez it’s just endless
No idea who these ‘bad guys’ are, just random
He just walked in and deleted everything, no backups at all? Too easy, unrealistic.
And then what was the point of that minor amount of ‘drama’ if they discover it anyway in the end? Eh?
A short story shouldn’t just be a springboard to a larger movie, it should stand on its own two feet.
Couple at end is cheesy
the Ferrari is nice though
and yes it’s easy to criticise etc
Eugene is actually a VO actor mainly now, he’s made it pretty big in that field. Unfortunately our talent field here is... limited, to say the least. And I agree with you it’s not that it’s just too much talking, it’s actually that nobody is doing anything while talking in too many scenes. I wouldn’t have done it that way except for limited locations I could use, limited time to film (and more actions mean more shooting days), and too few crew resources up here. We could do the basics but it didn’t translate into what I ultimately wanted. Even the scene you mentioned is not how it was scripted originally either, as far as him stealing the data. That was my only location where they literally kicked me out and I had to improvise a lame scenario.
I honestly only am happy with how the film turned out visually and the locations I could use. I also like the music (Ramin did Sharknado! Lol). I dislike the pacing, the acting is solid but it’s not great, the story is not a short so it doesn’t really work, and it bores me and I made it; it was a failed project. My only such one that didn’t go to many film festivals (3 I think), but it was the germ of an idea. I wrote an unrelated feature script called “The Death of Aging,” had nothing to do with the short though.
I fully agree it simply doesn’t stand on its own two feet as a short. An experiment, but it was almost like trying to cram feature ideas into a short time frame which means nothing gets developed properly. Also too many characters. A short should stay focused on one or two characters and keep it tight.
I do like that you hit the major talking points such as daily death, to death do us part, worries of overpopulation, etc.
The latest from Aubrey.
An interview with David Sinclair
I knew his father was taking "the stuff" but didn't know it was for a decade.
Ah here we go
The company, which has carried out preliminary tests on beagles, claims it will make animals “younger" by adding new DNA instructions to their bodies.
“We have already done a bunch of trials in mice and we are doing some in dogs, and then we’ll move on to humans,” Church told the podcaster Rob Reid earlier this year.
The company’s efforts to keep its activities out of the press make it unclear how many dogs it has treated so far. In a document provided by a West Coast veterinarian, dated last June, Rejuvenate said its gene therapy had been tested on four beagles with Tufts Veterinary School in Boston. It is unclear whether wider tests are under way.
“Dogs are a market in and of themselves,” Church said during an event in Boston last week. “It’s not just a big organism close to humans. It’s something people will pay for, and the FDA process is much faster. We’ll do dog trials, and that’ll be a product, and that’ll pay for scaling up in human trials.”
The Harvard group now plans to publish a scientific report on a technique that extends rodents’ lives by modifying two genes to act on four major diseases of aging: heart and kidney failure, obesity, and diabetes. According to Church, the results are “pretty eye-popping.”
In a January presentation about his project at Harvard, Davidsohn closed by displaying a picture of a white-bearded Church as he is now and another as he was decades ago, hair still auburn. Yet the second image was labelled 2117 AD—100 years in the future.
The images reflect Church’s aspirations for true age reversal. He says he’d sign up if a treatment proved safe, or even as a guinea pig in a study. Essentially, Church has said, the objective is to “have the body and mind of a 22-year-old but the experience of a 130-year-old.”